Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases

The present invention describes peptides comprising phycocyanobilin (PCB), as well as the medical use of said peptides and that of PCB, due to the neuroprotector and/or neuroregenerative effects identified for them. Furthermore, pharmaceutical combinations of said peptides and of PCB with proteins o...

Full description

Saved in:
Bibliographic Details
Main Authors Rodriguez Jimenez Efrain, Gonzalez Lopez Luis Javier, Llopiz Arzuaga Alexey, Penton Arias Eduardo, Guillen Nieto Gerardo Enrique, Pardo Andreu Gilberto Lazaro, Besada Perez Vladimir Armando, Pavon Fuentes Nancy, Musacchio Lasa Alexis, Lopez Saura Pedro Antonio, Penton Rol Giselle, Marin Prida Javier
Format Patent
LanguageEnglish
Published 13.12.2016
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention describes peptides comprising phycocyanobilin (PCB), as well as the medical use of said peptides and that of PCB, due to the neuroprotector and/or neuroregenerative effects identified for them. Furthermore, pharmaceutical combinations of said peptides and of PCB with proteins or other peptides with synergic effect justify their use for ischemic or neurodegenerative CNS disease treatment.
Bibliography:Application Number: US201214127369